The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Chiranjib Chakraborty(Hallym University), Sang‐Soo Lee(Hallym University), Manojit Bhattacharya(Fakir Mohan University), Govindasamy Agoramoorthy(Tajen University), Ashish Ranjan Sharma(Hallym University)
Cited by 167
Related Papers
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
|Molecular Therapy — Nucleic Acids|2017|727
Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach
|Journal of Medical Virology|2020|424
Therapeutic advances of miRNAs: A preclinical and clinical update
|Journal of Advanced Research|2020|404
Zebrafish: A complete animal model to enumerate the nanoparticle toxicity
|Journal of Nanobiotechnology|2016|344